Al Khayyat Investments (AKI) has announced the foray of its BinSina Pharmacy brand into Oman with the launch of a flagship outlet in Muscat. It is the first of several BinSina Pharmacy stores already planned to open across Oman in the coming months.
The brand’s entry into Oman is yet another step forward in AKI’s growth plans across the Middle East and North Africa region, which encompasses over 5,500 employees working across AKI’s various business divisions. BinSina was the UAE’s first pharmacy chain, and today has a growing network of more than 150 outlets.
“People today not only desire access to a diverse range of health offerings, but exceptional customer services and experiences when they shop. With a deep knowledge of the region’s retail and healthcare sectors, we realised that this is the right moment for us to explore more opportunities in Oman with our BinSina Pharmacy brand. It is one of several exciting projects in the country and part of our wider expansion plans across the MENA region,” said Zaid S. Al Khayyat, Managing Director of Al Khayyat Investments (AKI).
“Over the years, BinSina has become a name synonymous with the best products and services in the pharma sector. The ongoing success of BinSina Pharmacy allows us to continue growing and expanding our network of pharmacies in the GCC. With that opportunity, we are excited to bring our innovative and modernised approach to managing pharmacies and customer experiences to Oman,” said Dr. Doaa Marouf, Chief Executive Officer of Al Khayyat Investments (AKI) Pharma.
AKI currently has a footprint across eight countries in the wider Middle East and Africa region. The expansion of AKI’s retail business in Oman follows the conglomerate’s entry into Iraq, Saudi Arabia, and Egypt in 2022.